October 30, 2006 4:00 PM
- Text
Male Contraceptive Drug In The Works
- Chemo May Not Harm Unborn Baby
- C-Sections Not Always Best for Small Babies
- CDC: Doctors Increasingly Prescribe Exercise
- Osteoporosis Medication Linked to Unusual Thigh Fractures
- Some Men May Inherit a Higher Risk of Heart Disease From Dad
- Tai Chi Improves Symptoms of Parkinson?s Disease
- More from WebMD »
(WebMD)
Scientists report promising results with a male contraceptive drug tested on rats.
The drug, called Adjudin, is a long way from human use. But lab tests on rats showed no signs of side effects, and the drug's effects wore off in 20 weeks.
The researchers included Chuen-yan Cheng, PhD, of the Population Council's Center for Biomedical Research. The Population Council is a New York-based international nonprofit organization that conducts biomedical, social science, and public health research.
About Adjudin
Basically, Adjudin nips wannabe sperm cells in the bud. Those cells, called germ cells, ordinarily develop into sperm. But they need the help of other cells, called Sertoli cells, to reach that destiny.
Adjudin interferes with the process.
Cheng's team previously reported from other animal tests that Adjudin, given orally by itself, was too toxic to be a suitable contraceptive because it caused liver inflammation and muscle shrinkage (atrophy).
So the scientists bundled Adjudin with a synthetic version of the sex hormone FSH (follicle-stimulating hormone) and injected it into the bellies of four male rats.
The researchers played matchmaker four, six, 12, and 20 weeks later, putting the treated rats in cages with virgin female rats for two to four days.
For comparison, they put male rats that hadn't gotten the contraceptive in other cages with female rats.
The male and female rats mated, as expected.
All the male rats that had gotten the contraceptive shots were infertile four and six weeks after treatment. Their fertility resumed 20 weeks after getting the shots. That shows the contraceptive is "reversible," the researchers write.
In comparison, all the female rats that mated with the untreated male rats gave birth to baby rats.
No side effects were reported in the treated rats.
By Miranda Hitti
Reviewed by Louise Chang
The drug, called Adjudin, is a long way from human use. But lab tests on rats showed no signs of side effects, and the drug's effects wore off in 20 weeks.
The researchers included Chuen-yan Cheng, PhD, of the Population Council's Center for Biomedical Research. The Population Council is a New York-based international nonprofit organization that conducts biomedical, social science, and public health research.
About Adjudin
Basically, Adjudin nips wannabe sperm cells in the bud. Those cells, called germ cells, ordinarily develop into sperm. But they need the help of other cells, called Sertoli cells, to reach that destiny.
Adjudin interferes with the process.
Cheng's team previously reported from other animal tests that Adjudin, given orally by itself, was too toxic to be a suitable contraceptive because it caused liver inflammation and muscle shrinkage (atrophy).
So the scientists bundled Adjudin with a synthetic version of the sex hormone FSH (follicle-stimulating hormone) and injected it into the bellies of four male rats.
The researchers played matchmaker four, six, 12, and 20 weeks later, putting the treated rats in cages with virgin female rats for two to four days.
For comparison, they put male rats that hadn't gotten the contraceptive in other cages with female rats.
The male and female rats mated, as expected.
All the male rats that had gotten the contraceptive shots were infertile four and six weeks after treatment. Their fertility resumed 20 weeks after getting the shots. That shows the contraceptive is "reversible," the researchers write.
In comparison, all the female rats that mated with the untreated male rats gave birth to baby rats.
No side effects were reported in the treated rats.
SOURCES: Mruk, D. Nature Medicine, Oct. 29, 2006; advance online publication. WebMD Medical News: "Gene Therapy Offers Hope to Infertile Men." News release, Nature and the Nature research journals.
By Miranda Hitti
Reviewed by Louise Chang
Popular Now in Health
- America's sodium problem: Not from salty snacks?
- Caffeine inhalers - the next club drug?
- Chinese mom gives birth to 15-pound baby
- Norovirus outbreak hits Rider University in N.J
- Electric shocks to brain may boost memory: Study
- STD rates rise among elderly: Why?
- Skin cancer self-exam: What to look for (PHOTOS)
- Scottish twins, 102, are world's oldest: Guinness
- Things You Didn't Know About Your Penis
- Measles patient at Super Bowl prompts health alert
- Deep vein thrombosis risk low in economy class
- Drinking soda raises risk for asthma, COPD: Study
- College sells morning-after pill in vending machine
- Green tea linked to less disability in elderly
- PICTURES: 15 Shocking Sexual Fetishes
- Egg recall in 34 states over Listeria concerns
- Online dating full of downsides, new study says
Latest CBS News Headlines
on Facebook
on CBS News
- Generics drugs help PharMerica to bigger 4Q profit
- What earnings reports reveal about entertainment
- Federal agency looking at high-frequency traders
- Backers of Mo. tax plan committed to Nov. vote
on Facebook
- Adele opens up about vocal cord surgery
- Tenn. father charged with murdering couple who"unfriended" daughter on Facebook
- Mo. teen gets life in prison for murder of 9-year-old girl
- "American Idol": Jim Carrey's daughter out, and then disaster
on CBS News






